1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Nivolumab with ipilimumab for untreated advanced renal cell carcinoma

Technology appraisal guidance [TA780] Published: 24 March 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Committee papers (TA780) PDF 2.71 MB 24 March 2022  
  • Appraisal consultation committee papers (TA581) PDF 7.05 MB 15 May 2019  
  • Final appraisal determination committee papers (TA581) PDF 2.8 MB 15 May 2019